Targeted Next Generation Sequencing (NGS) for the Identification of Clinically Actionable Mutations in Advanced Stage/Recurrent Endometrial Carcinoma (EC)

被引：0
|
作者：
Singh, Charanjeet [1 ]
Routbort, Mark [1 ]
Broaddus, Russell [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1234
引用
收藏
页码：307A / 307A
页数：1
相关论文
共 50 条
  • [1] Targeted Next Generation Sequencing (NGS) for the Identification of Clinically Actionable Mutations in Advanced Stage/Recurrent Endometrial Carcinoma (EC)
    Singh, Charanjeet
    Routbort, Mark
    Broaddus, Russell
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 307A - 307A
  • [2] Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
    Lu, Hongyang
    Yang, Shifeng
    Zhu, Huineng
    Tong, Xiaoling
    Xie, Fajun
    Qin, Jing
    Han, Na
    Wu, Xue
    Fan, Yun
    Shao, Yang W.
    Mao, Weimin
    [J]. BMC CANCER, 2018, 18
  • [3] Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
    Hongyang Lu
    Shifeng Yang
    Huineng Zhu
    Xiaoling Tong
    Fajun Xie
    Jing Qin
    Na Han
    Xue Wu
    Yun Fan
    Yang W. Shao
    Weimin Mao
    [J]. BMC Cancer, 18
  • [4] Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
    Jeck, William R.
    Parker, Joel
    Carson, Craig C.
    Shields, Janiel M.
    Sambade, Maria J.
    Peters, Eldon C.
    Burd, Christin E.
    Thomas, Nancy E.
    Chiang, Derek Y.
    Liu, Wenjin
    Eberhard, David A.
    Ollila, David
    Grilley-Olson, Juneko
    Moschos, Stergios
    Hayes, D. Neil
    Sharpless, Norman E.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (04) : 653 - 663
  • [5] Identification of potentially actionable mutations in RTKs in melanoma detected by next generation sequencing (NGS)
    Kemnade, Jan
    Roszik, Jason
    Joon, Aron
    Stingo, Franceso
    Baladandayuthapani, Veera
    Lazar, Alexander J. F.
    Woodman, Scott Eric
    Davies, Michael A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] The efficacy of targeted next-generation sequencing for detection of clinically actionable mutations in cancer
    Wen, Yu-Ye
    Fang, Erica
    Li, Yanchun
    Carmack, Condie Edwin
    Li, Marilyn M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Next generation cancer gene sequencing for clinically actionable mutations
    Wen, Yu-Ye
    Douglas, Ganka
    Hu, Xiafeng
    Millham, Michele
    Cifuentes, Francisco
    Peters, Garrick
    Carmack, Condie Edwin
    Li, Marilyn
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Detection of Rare Clinically Actionable Mutations in NSCLC Metastatic to the Brain by Targeted Next Generation Sequencing
    Tafe, Laura J.
    Maung, Ko K.
    Weinstein, Shelsey J.
    Tsongalis, Gregory J.
    Dragnev, Konstantin H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S310 - S310
  • [9] Next Generation Sequencing (NGS) Identifies Actionable Mutations in Glioblastoma Multiforme (GBM)
    Khan, Mohammad
    Khullar, Gaurav
    Bannykh, Serguei
    Engman, David
    Vail, Eric
    Lopategui, Jean
    Fan, Xuemo
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 534 - 534
  • [10] Detecting Clinically Actionable Mutations in Leukemia Using a Novel Targeted Next-Generation Sequencing Panel
    Chang, F.
    Liu, L.
    Fang, E.
    Zhang, G.
    Li, Y.
    Li, M. M.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 869 - 869
12345